You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

active surveillance

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Reporting to Identify Adverse Events Following Chiropractic Care

Recruiting
  • Musculoskeletal Pain
  • Musculoskeletal Symptoms
  • Active Surveillance Reporting System
  • Toronto, Ontario, Canada
    Canadian Memorial Chiropractic College
Apr 22, 2022

European Active Surveillance Study of LCS12

Recruiting
  • Contraception
    • Berlin, Germany
      Center for Epidemiology and Health Research Berlin
    Feb 23, 2022

    Prostate Cancer Trial run by the National Cancer Institute (NCI) (mpMRI)

    Recruiting
    • Prostate Cancer
    • mpMRI
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 24, 2022

    Active Surveillance in Prostate Cancer

    Completed
    • Prostate Cancer
    • Survey
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Apr 1, 2022

    Prostatic Tumors Trial in Herlev (multiparametric MRI Diagnostics)

    Enrolling by invitation
    • Prostatic Neoplasms
    • multiparametric MRI Diagnostics
    • Herlev, Denmark
      Department of Urology, Herlev University Hospital Herlev
    Mar 25, 2022

    Prostatic Tumors, Prostate Cancer Trial (Vitamin D (Calcitriol))

    Withdrawn
    • Prostatic Neoplasms
    • Prostate Cancer
    • Vitamin D (Calcitriol)
    • (no location specified)
    Feb 14, 2022

    STHLM3 AS NorDCaP -Followup Study of Men on Active Surveillance

    Recruiting
    • Prostate Cancer
    • Stockholm3 test
    • Stockholm, Solna, Sweden
      Karolinska Institutet
    Mar 29, 2022

    Advanced Rectal Cancer Trial in Rochester (FOLFOX)

    Active, not recruiting
    • Advanced Rectal Cancer
    • Rochester, New York
    • +1 more
    Jun 9, 2022

    Prostate Cancer Trial in Cleveland (virtual biopsy (VB) monitoring protocol)

    Withdrawn
    • Prostate Cancer
    • virtual biopsy (VB) monitoring protocol
    • Cleveland, Ohio
      University Hospitals Seidman Cancer Center, Case Comprehensive C
    May 16, 2022

    Bladder Cancer Trial in Barcelona (Endoscopic fulguration)

    Not yet recruiting
    • Bladder Cancer
    • Endoscopic fulguration
    • Barcelona, Spain
      Fernando Lozano Palacio
    Dec 7, 2021

    Nevoid Basal Cell Carcinomas in Gorlin Syndrome

    Enrolling by invitation
    • Basal Cell Carcinoma
    • Gorlin Syndrome
    • Active surveillance
    • Oslo, Norway
      Oslo University Hospital
    Jun 8, 2023

    Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v8, Stage IIA Rectal Cancer AJCC v8 Trial in Houston (drug, other, procedure)

    Not yet recruiting
    • Rectal Adenocarcinoma
    • +8 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 25, 2022

    Diabetes, Diabetes, Type 2, Medullary Thyroid Carcinoma Trial in Morgantown (No treatment given)

    Enrolling by invitation
    • Diabetes
    • +3 more
    • No treatment given
    • Morgantown, West Virginia
      United BioSource, LLC
    Oct 4, 2022

    Prostate Cancer Trial (Apalutamide Oral Tablet [Erleada], Placebo)

    Not yet recruiting
    • Prostate Cancer
    • Apalutamide Oral Tablet [Erleada]
    • Placebo
    • (no location specified)
    Jan 11, 2022

    Prostate Cancer Trial in Dallas (Curcumin, Placebo)

    Recruiting
    • Prostate Cancer
    • Dallas, Texas
      UT Southwestern Medical Center
    Jan 25, 2022

    Hepatitis Immune Trial (Active Surveillance, Early initiation)

    Not yet recruiting
    • Hepatitis Immune
    • Active Surveillance
    • Early initiation
    • (no location specified)
    Jul 14, 2022

    Prostate Adenocarcinoma, Prostate Cancer Trial in San Francisco (Hyperpolarized Carbon C 13 Pyruvate, Magnetic Resonance

    Recruiting
    • Prostate Adenocarcinoma
    • Prostate Cancer
    • Hyperpolarized Carbon C 13 Pyruvate
    • +2 more
    • San Francisco, California
      University of California, San Francisco
    Oct 3, 2022

    Prostate Active Surveillance Study

    Recruiting
    • Prostatic Neoplasms
      • San Francisco, California
      • +9 more
      Jul 5, 2022

      Multiparametric MRI in Prostate Cancer Undergoing Active

      Enrolling by invitation
      • Prostatic Neoplasms
        • Herlev, Denmark
          Department of Urology, Herlev University Hospital Herlev
        Oct 15, 2021

        Assess Safety of Ozanimod in Moderate to Severe Active UC in

        Not yet recruiting
        • Ulcerative Colitis
        • Seoul, Korea, Republic of
          Bristol-Myers Squibb YH
        Oct 3, 2023

        Prostate Adenocarcinoma Trial in Seattle (Apalutamide, Laboratory Biomarker Analysis, Quality-of-Life Assessment)

        Terminated
        Has Results
        • Prostate Adenocarcinoma
        • Seattle, Washington
          Fred Hutch/University of Washington Cancer Consortium
        Dec 28, 2021

        Solitary Pulmonary Nodule, Coin Lesion, Pulmonary, Lung Tumors Trial in Pasadena (More Frequent Surveillance Strategy, Less

        Active, not recruiting
        • Solitary Pulmonary Nodule
        • +3 more
        • More Frequent Surveillance Strategy
        • Less Frequent Surveillance Strategy
        • Pasadena, California
          Kaiser Permanente Southern California
        Sep 30, 2022

        Adenocarcinoma of the Prostate, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in Los Angeles (behavioral, dietary

        Active, not recruiting
        • Adenocarcinoma of the Prostate
        • +3 more
        • behavioral dietary intervention
        • +2 more
        • Los Angeles, California
          Jonsson Comprehensive Cancer Center
        Apr 4, 2022

        Localized Prostate Cancer Under Active Surveillance

        Withdrawn
        • Prostate Cancer
        • (no location specified)
        Oct 14, 2021

        Prostate Cancer Trial (Lower-Carbohydrate Med-t-Diet, Low-Fat Med-t-Diet)

        Not yet recruiting
        • Prostate Cancer
        • Lower-Carbohydrate Med-t-Diet
        • Low-Fat Med-t-Diet
        • (no location specified)
        Dec 12, 2022